La ligne téléphonique n’est pas disponible pour le moment.Pour toute demande veuillez envoyer un email a support@advfn.fr

Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance

Date : 08/04/2019 @ 07h46
Source : Dow Jones News
Valeur : Sanofi (SNY)
Cours : 41.57  0.0 (0.00%) @ 02h00
Sanofi Cours Graphique

Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance

Sanofi (EU:SAN)
Graphique Historique de l'Action

6 Mois : De Jan 2019 à Juil 2019

Plus de graphiques de la Bourse Sanofi
   By Nathan Allen 
 

Sanofi SA (SAN.FR) said Monday that it has concluded the research-and-option phase of its rare-disease alliance with Alnylam Pharmaceuticals Inc. (ALNY)

Through the alliance, which was set up in 2014, the companies developed a treatment for patients with ATTR amyloidosis and are testing a molecule to treat hemophilia, Sanofi said.

In the new phase of the alliance Alnylam will proceed with another early-stage therapy for an undisclosed rare disease, taking it through to initial trials.

Sanofi said it will then be responsible for any further development of the therapy, paying royalties to Alnylam from global sales.

The two companies have amended their equity agreement, with France's Sanofi obtaining a release from its lock-up of trading in Alnylam's shares.

 

Write to Nathan Allen at nathan.allen@dowjones.com

 

(END) Dow Jones Newswires

April 08, 2019 01:31 ET (05:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Dernières Valeurs Consultées
EU
GLE
Société Gé..
EU
ALU
ALCATEL-LU..
EU
PX1
CAC 40
ORA
Orange
FX
EURUSD
Euro vs Do..
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.


Inscrivez-vous maintenant pour créer votre liste d'actions personnalisée, en streaming.

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V:fr D:20190718 07:06:22